Provided by Tiger Fintech (Singapore) Pte. Ltd.

bioAffinity Technologies, Inc.

2.94
-0.4700-13.78%
Post-market: 2.93-0.0100-0.34%19:59 EDT
Volume:701.51K
Turnover:2.15M
Market Cap:13.23M
PE:-0.14
High:3.22
Open:3.20
Low:2.94
Close:3.41
52wk High:67.12
52wk Low:2.34
Shares:4.50M
Float Shares:4.50M
Volume Ratio:0.16
T/O Rate:15.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-20.7848
EPS(LYR):-22.3665
ROE:-1802.45%
ROA:-110.27%
PB:-6.19
PE(LYR):-0.13

Loading ...

Why Did bioAffinity Technologies' Stock Slip In After-Hours Trading After A Big Day Of Gains?

Benzinga_recent_news
·
Oct 17

bioAffinity Technologies Receives USPTO Allowance for Patent Covering AI-Based Lung Cancer Diagnostic Test

Reuters
·
Oct 16

bioAffinity Technologies Announces Notification of Allowance for U.S. Patent Application for Its Diagnostic Algorithm and Test Method for Lung Cancer

THOMSON REUTERS
·
Oct 16

bioAffinity Technologies Regains Nasdaq Compliance, Avoids Delisting After Meeting Listing Standards

Reuters
·
Oct 15

bioAffinity Technologies Regains Compliance With Nasdaq Listing Requirements

THOMSON REUTERS
·
Oct 15

Wallachbeth Capital Announces the Closing of bioAffinity Technologies $1.8M Registered Direct Financing of Common Stock Priced at-the-Market Under Nasdaq Rules

THOMSON REUTERS
·
Oct 10

bioAffinity Technologies Inc. Announces Date for Upcoming Special Meeting of Stockholders

Reuters
·
Oct 09

BRIEF-Wallachbeth Capital Announces Bioaffinity Technologies

Reuters
·
Oct 09

BioAffinity Technologies announces $1.8M registered direct offering

TIPRANKS
·
Oct 09

bioAffinity Technologies announces 18 million registered direct offering of common stock to support CyPath Lung sales and working capital

Reuters
·
Oct 09

bioAffinity Technologies, Inc. Announces Approximately $1.8 Million Registered Direct Financing of Common Stock Priced at-the-Market Under Nasdaq Rules

THOMSON REUTERS
·
Oct 09

What's Driving bioAffinity Technologies' Big Pre-Market Surge?

Benzinga
·
Oct 08

bioAffinity Technologies reports record growth in CyPath Lung test sales in third quarter 2025

Reuters
·
Oct 07

BRIEF-Wallachbeth Capital announces pricing of Bioaffinity Technologies public offering for $4.8 mln

Reuters
·
Sep 30

Wallachbeth Capital Announces Pricing of bioAffinity Technologies Public Offering for $4.8M

THOMSON REUTERS
·
Sep 30

BioAffinity prices 1.92M common share offering at $2.50 per share

TIPRANKS
·
Sep 30

bioAffinity Technologies Announces $4.8 Million Public Offering of Common Stock and Pre-Funded Warrants

Reuters
·
Sep 30

bioAffinity Technologies Announces Pricing of $4.8 Million Public Offering

THOMSON REUTERS
·
Sep 30

bioAffinity Technologies Inc trading halted, volatility trading pause

TIPRANKS
·
Sep 29

Nasdaq Gains 100 Points; US Consumer Sentiment Falls

Benzinga
·
Sep 27